Neural connectivity moderators and mechanisms of ketamine treatment among treatment-resistant depressed patients: a randomized controlled trialResearch in context
Summary: Background: Intravenous (IV) ketamine has emerged as a rapid and effective treatment for TRD. However, the specific neural mechanisms of ketamine's effects in humans remains unclear. Although neuroplasticity is implicated as a mechanism of action in animal models, relatively few rando...
Main Authors: | Manivel Rengasamy, Sanjay Mathew, Robert Howland, Angela Griffo, Benjamin Panny, Rebecca Price |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-01-01
|
Series: | EBioMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396423004681 |
Similar Items
-
Editorial: Ketamine for treatment of acute and chronic pain: The relationship of mechanism and exposure to therapeutic outcome
by: Albert Dahan, et al.
Published: (2022-08-01) -
Copper Concentrations in Ketamine Therapy for Treatment-Resistant Depression
by: Jakub Słupski, et al.
Published: (2020-12-01) -
Functional connectivity between the amygdala and subgenual cingulate gyrus predicts the antidepressant effects of ketamine in patients with treatment‐resistant depression
by: Tomoyuki Nakamura, et al.
Published: (2021-06-01) -
The Role of Ketamine in the Treatment of Bipolar Depression: A Scoping Review
by: Muhammad Youshay Jawad, et al.
Published: (2023-06-01) -
Effect of Ketamine in the Treatment of Patients with Major Depressive Disorder
by: F Kheirkhah, et al.
Published: (2010-10-01)